beta
Trial Radar AI
Clinical Trial NCT07442175 for Atrial Fibrillation (AF) is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial 392

Recruiting
Clinical Trial NCT07442175 is an observational study for Atrial Fibrillation (AF) that is recruiting. It started on 9 February 2026 with plans to enroll 392 participants. Led by Andon Health Co., Ltd, it is expected to complete by 30 July 2026. The latest data from ClinicalTrials.gov was last updated on 2 March 2026.
Brief Summary
This study evaluates the accuracy of a blood pressure monitor in detecting atrial fibrillation by comparing its results with a standard diagnostic method.
Official Title

Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial

Conditions
Atrial Fibrillation (AF)
Other Study IDs
  • Andon Health 18
NCT ID Number
NCT07442175
Start Date (Actual)
2026-02-09
Last Update Posted
2026-03-02
Completion Date (Estimated)
2026-07-30
Enrollment (Estimated)
392
Study Type
Observational
Status
Recruiting
Arms / Interventions
Participant Group/ArmIntervention/Treatment
Subjects use Blood Pressure Monitor (TH-75) and ECG
N/A
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Accuracy of atrial fibrillation detection by the TH-75 blood pressure monitor, assessed against the prespecified acceptance criteria.
Baseline
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
22 Years
Eligible Sexes
All

Atrial Fibrillation (AF):

  • Age ≥ 22 years;
  • Arm circumference between 22 cm and 42 cm;
  • Diagnosed with atrial fibrillation by a qualified medical institution.

Non-Atrial Fibrillation:

  • Age ≥ 22 years;
  • Arm circumference between 22 cm and 42 cm;
  • No prior diagnosis of atrial fibrillation.

  • Pregnant women
  • Presence of an implanted cardiac pacemaker and/or defibrillator
  • Inability to cooperate with blood pressure measurement or ECG assessment
  • Any condition that, in the opinion of the investigator, makes the participant unsuitable for participation in this clinical study
Andon Health Co., Ltd logoAndon Health Co., Ltd
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine logoFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Study Central Contact
Contact: Jing Li, 022-87611660, [email protected]
1 Study Locations in 1 Countries

Tianjin Municipality

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, Tianjin Municipality, 300381, China
Tianqing Ni, Contact, 022-27986255, [email protected]
Recruiting